Abstract
The 2-arylpropionic acid nonsteroidal anti-inflammatory drugs are usually administered as racemates. The enantiomers may have different pharmacokinetics and the R-isomer may metabolically invert to the S-isomer. To pinpoint the kinetics of the inversion and the location in which this metabolic process takes place, racemic ketoprofen (KT) was administered to the rat. Using a stereospecific HPLC assay, the pharmacokinetics of KT were studied following 10 mg/kg iv, po, and ip doses of racemic KT to male Sprague-Dawley rats. Plasma concentrations were always greater for (S)-KT than for (R)-KT. The mean +/- SD AUC S/R ratios were 11.8 +/- 9.93 (N = 5), 11.0 +/- 2.64 (N = 4), and 33.7 +/- 11.2 (N = 5) after iv, ip, and po doses, respectively. Bile duct-cannulated rats (N = 4) had AUCs of 85.4 +/- 58.6 and 22.8 +/- 18.4 (mg/liter) hr for (S)- and (R)-KT, respectively. The percentage of conjugated drug recovered in bile was 77.9 +/- 3.77 and 11.4 +/- 2.48% of the dose as (S)- and (R)-KT, respectively. The data indicate 1) substantial stereoselectivity, 2) presystemic gastrointestinal and systemic inversion of (R)- to (S)-KT, 3) extensive elimination of drug through bile in rats, and 4) extensive reabsorption subsequent to biliary excretion.
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|